Article Information
History
- December 15, 2021.
Article Versions
- Version 1 (December 13, 2021 - 08:37).
- You are currently viewing Version 2 of this article (December 15, 2021 - 11:26).
- Version 3 (December 22, 2021 - 08:07).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maren Schubert1,*,
- Federico Bertoglio1,*,
- Stephan Steinke1,
- Philip Alexander Heine1,
- Mario Alberto Ynga-Durand2,
- Fanglei Zuo3,
- Likun Du3,
- Janin Korn1,4,
- Marko Milošević5,
- Esther Veronika Wenzel1,4,
- Henrike Maass2,
- Fran Krstanović6,
- Saskia Polten1,
- Marina Pribanić-Matešić6,
- Ilija Brizić6,
- Antonio Piralla7,
- Fausto Baldanti7,8,
- Lennart Hammarström3,
- Stefan Dübel1,
- Alan Šustić5,
- Harold Marcotte3,
- Monika Strengert9,
- Alen Protić5,
- Qiang Pan-Hammarström3,#,
- Luka Čičin-Šain2,10,# and
- Michael Hust1,#&
- 1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
- 2Helmholtz Centre for Infection Research, Department of Viral Immunology, Inhoffenstr. 7, 38124 Braunschweig, Germany
- 3Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
- 4Abcalis GmbH, Science Campus Braunschweig-Süd, Inhoffenstr. 7, 38124 Braunschweig, Germany
- 5Department of Anesthesiology, Reanimation, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
- 6Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
- 7Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
- 8Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy
- 9Department of Epidemiology, Helmholtz Centre for Infection Research, Inhoffenstr. 7, 38124 Braunschweig, Germany
- 10Centre for Individualised Infection Medicine (CIIM), a joint venture of Helmholtz Centre for Infection Research and Medical School Hannover
- ↵&Corresponding author: Michael Hust, Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany, email: m.hust{at}tu-bs.de
↵* These authors contributed equally
Posted December 15, 2021.
Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
